Navigation Links
Sundia in Top 100 Fast-growth Outsourcing Companies in China
Date:7/20/2009

SHANGHAI, July 20 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, announced today that the company was named as a Top 100 Fast-growth Outsourcing Service Provider. This selection was jointly sponsored by China Council for International Investment Promotion (CCIIP) and three global leading market researchers, TPI, IDC and Gartner. This ranking covers outsourcing services in IT, pharmaceutical, biotech, and all industrial fields. The list was announced at the 2nd China International Outsourcing Service Cooperation Conference.

The Top 100 outsourcing ranking was determined based on company size and growth rate, business income, and per headcount revenue. As a leading pharmaceutical R&D CRO company, Sundia is consistently focused on providing high quality CRO services to pharmaceutical and biotech company clients worldwide. Since its founding in 2004, the company's CRO service business has been growing at a high rate. "We are very pleased and honored to be included in this list," Commented Dr. Xiaochuan Wang, Chairman and CEO of Sundia. "It is another recognition of the effort of all of our team members."

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
2. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
3. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
4. Sundias Animal Facility Passed Client and Government Inspection
5. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
6. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
7. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
8. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
9. 2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
10. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
11. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... India , February 17, 2017 ... report "Biomarkers Market by Product (Consumables, Service), Type ... Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) ... the market is projected to reach USD 53.34 ... 2016, growing at a CAGR of 13.8% during ...
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital has ... at the agricultural industry. Pilot studies are about to get under way for the ... Data and 5G innovations. The concept is expected to be transferred eventually to other ...
(Date:2/16/2017)... Calif. , Feb. 16, 2017  ArmaGen, ... developing groundbreaking therapies to treat severe neurological disorders, ... children treated with AGT-181, the company,s investigational therapy ... (also known as mucopolysaccharidosis type I, or MPS ... 2 proof-of-concept (POC) study, presented today at the ...
(Date:2/16/2017)... UCHealth ( Aurora, Colorado ) becomes the ... management. In addition to optimizing care coordination for patients ... UCHealth looks to improve provider workflow by decreasing the ... Stephanie Brown, RN , Thoracic Nurse Navigator, says, "I ... spreadsheet, which was extremely arduous and susceptible to error.  ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
Breaking Biology News(10 mins):